Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TAL2
REST API REST API
Homo sapiens
TAL2 is differentially expressed in 87 experiments: 45 organism parts: cervix, endometrium, ... (43 more);, 27 disease states: normal, AF, ... (25 more);, 26 cell types 37 cell lines 11 compound treatments and 40 other conditions.
Synonyms bHLHa19
Orthologs Tal2 (Rattus norvegicus)   TAL2 (Gallus gallus)   Tal2 (Mus musculus)   HLH3B (Drosophila melanogaster)   tal2 (Danio rerio)   tal2 (Xenopus laevis)   TAL2 (Canis familiaris)   TAL2 (Bos taurus)   (Compare orthologs)
Gene Ontology Term DNA binding, behavior, regulation of transcription, DNA-dependent, multicellular organism growth, nucleus, post-embryonic development, thalamus development, midbrain development
InterPro Term HLH_DNA-bd
UniProt Accession Q16559
Search EB-eye ENSG00000186051
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-8167, E-MTAB-37, E-GEOD-22541, E-GEOD-18105, E-MTAB-69, ... (9 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-MTAB-37, E-GEOD-5823, E-MEXP-2034, E-GEOD-20089, ... (10 experiments)

Factor Value U/D Experiments
Jurkat
1
E-MEXP-2197
ZR75-1
1
E-GEOD-19639
SNU449
1
E-MTAB-37
SW1573
1
E-MTAB-37
MDA-MB-231
1
E-GEOD-5823
MDA435
1
E-GEOD-20089
31 more value(s).


Cell type

studied in E-GEOD-18811, E-GEOD-22373, E-TABM-130, E-MEXP-750, E-GEOD-20677, ... (13 experiments)

Factor Value U/D Experiments
plasma cell
1
E-MEXP-2360
Embryonic Kidney cell
1
1
E-GEOD-20677
not specified
1
E-GEOD-18811
macrophage
1
E-GEOD-22373
native fetal RPE
1
E-GEOD-18811
osteoblast
1
E-MEXP-1216
20 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-15960, E-MEXP-2069, E-GEOD-23878, ... (16 experiments)

Factor Value U/D Experiments
normal
2
5
E-GEOD-6338, E-TABM-702, E-TABM-282, E-GEOD-13501, E-GEOD-7307, ... (7 experiments)
gulf war illness
1
E-MEXP-2069
anaplastic large cell lymphoma
1
1
E-GEOD-6338
colorectal cancer
1
E-GEOD-15960
colorectal carcinoma
1
E-GEOD-23878
amyotophic lateral sclerosis
1
E-GEOD-3307
21 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-15205, E-TABM-868, E-MEXP-2241, E-GEOD-7307, ... (6 experiments)

Factor Value U/D Experiments
bacterial endotoxin
1
1
E-GEOD-3284
control
10
1
E-GEOD-3284
ethanol
1
E-MEXP-2241
lipopolysaccharide
1
E-TABM-868
none
1
E-TABM-868
TGF
1
1
E-GEOD-15205
5 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21374, E-GEOD-18995 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22541, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-GEOD-17476, E-TABM-868, E-TABM-601

Growth condition
studied in E-MEXP-2657, E-GEOD-20540

Individual
studied in E-MEXP-1828, E-GEOD-3284, E-MEXP-1243, E-MEXP-2069, E-GEOD-19330, ... (12 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Tumor grading
studied in E-GEOD-22541

Processing time: 0.528 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM